What’s actually slowing this PC down?

Pick the symptom - the matching free tool is one click away.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

The stock is West Pharmaceutical Services (NYSE: WST), identified in a CNBC Best Stocks in the Market article attributed to Josh Brown and Sean Russo and dated October 1, 2026. The article’s indexed opening connects West with injectable medicines, but that clue identifies the company—not whether its shares are a good investment.

Which company is Josh Brown’s article about?

The indexed CNBC article identifies West Pharmaceutical Services, ticker WST. A Muck Rack profile indexing the CNBC article attributes it to Josh Brown and Sean Russo and dates it October 1, 2026. The headline also appears in Headline Arena’s index.

Why is West linked to shots and vaccines?

The indexed opening says that someone who has received a shot, vaccine, or injectable prescription has likely encountered something West makes somewhere in how that drug reached them. That is the article’s broad supply-chain framing; the available excerpt does not identify a particular product or explain West’s precise role in the delivery of any specific medicine.

The wording comes from an indexed excerpt rather than the complete CNBC story or company documentation. It should not be read as confirmation that West supplied a component for any particular patient’s treatment.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Does that connection make WST a buy?

No investment conclusion follows from the identification alone. The available article indexes do not establish West’s current revenue, earnings, valuation, guidance, customer exposure, or risks. Without those details, the connection to injectable medicines is context—not a basis for calling the stock attractive or recommending it.

A fuller assessment would require reviewing West’s current filings and investor-relations materials, including its business composition, operating results, disclosed customer and end-market exposure, capital allocation, risks, and outlook, then weighing those facts against the share price. The indexes that identify the CNBC story do not provide that analysis.

Rank #2

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi